Does Medicare Cover Ozempic and GLP-1 Drugs in 2026? What Changed and What to Do Now

Ozempic is FDA-approved primarily for the management of type 2 diabetes. Medicare Part D plans are permitted to cover it for this indication, and many do. However, coverage is not guaranteed: each Part D plan maintains its own formulary (list of covered drugs), and Ozempic may be on Tier 3, Tier 4, or not covered at all depending on the plan.

When a plan does cover Ozempic for diabetes, prior authorization is almost always required. Your doctor must document that you have a type 2 diabetes diagnosis and typically that other first-line medications have been tried. The prior authorization process can take several days to a few weeks.

If your plan covers Ozempic but places it on a high tier, your cost-share before reaching the deductible can be substantial. In 2026, the Part D deductible is $590. After the deductible, you pay your plan's cost-sharing until you reach the $2,100 out-of-pocket cap, after which your drug costs are $0 for the rest of the year.

Medicare has historically excluded weight loss drugs from Part D coverage under a statutory exclusion. Ozempic prescribed solely for weight management falls under this exclusion and is not covered.

The landscape changed in 2024 when CMS issued guidance allowing Part D plans to cover Wegovy (the higher-dose semaglutide formulation approved for chronic weight management) for Medicare beneficiaries who have both obesity and established cardiovascular disease. This was a significant policy shift, but it applies to Wegovy specifically, not to Ozempic prescribed off-label for weight loss.

For 2026, the rule remains: Ozempic for weight loss alone is not covered. Wegovy for cardiovascular risk reduction in patients with obesity may be covered depending on your plan. Check your plan's formulary or call our office at 813-699-5559 for a free plan review.

One of the most significant changes for Medicare beneficiaries in 2026 is the $2,100 out-of-pocket cap on Part D drug costs. This is a reduction from the $2,000 cap that took effect in 2025 as part of the Inflation Reduction Act.

For beneficiaries taking high-cost GLP-1 medications, this cap provides meaningful financial protection. Once your total out-of-pocket drug spending reaches $2,100 in a calendar year, you pay $0 for covered drugs for the rest of the year. This applies to all covered Part D drugs, including Ozempic when covered for diabetes.

The cap does not help if your drug is not covered by your plan at all. This is why plan selection matters enormously for GLP-1 users. A plan that covers Ozempic on Tier 3 versus Tier 4 can mean a difference of hundreds of dollars before you reach the cap. Our agents compare every plan's formulary and cost-sharing structure for your specific medications at no cost. See the official Medicare.gov Part D coverage page for the latest official guidance.

If your current Part D plan does not cover Ozempic, Wegovy, or another GLP-1 drug you need, you have several options.

First, ask your doctor to submit a formulary exception request. If you have tried covered alternatives and they were not effective or caused side effects, your doctor can document this and request that your plan cover the drug as an exception. This process takes time but is worth pursuing.

Second, compare plans during the Annual Enrollment Period (October 15 to December 7). Use Medicare Plan Finder to search for Part D plans that include your specific medication on their formulary. Filter by your drugs to see total estimated annual costs including premiums and cost-sharing. Our agents can run this comparison for you at no cost.

Third, check whether you qualify for Extra Help (also called the Low Income Subsidy). If your income and assets fall below certain thresholds, Extra Help significantly reduces your Part D premiums, deductibles, and cost-sharing for all covered drugs. See our guide to reducing Medicare costs based on income for eligibility details.